Key facts
- It has raised $36.3M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Zizhu Xiaomiao PE, Yijing Capital, Cherami Investment Group, The Hina Group, Lishui Green Industry Development Fund — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Yizhun AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Yizhun AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yizhun AI
Developer of medical imaging technology designed for the detection of nodules and tumors in the lungs and mammary glands. The company's technology utilizes artificial intelligence to more quickly identify malignant entities, enabling healthcare processionals to make accurate diagnoses.
- Sector
- Information Technology
- HQ
- Beijing, China
- Founded
- 2017
- Website
- yizhun-ai.com/
- Ownership
- Privately Held (backing)
Yizhun AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yizhun AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yizhun AI in its N-PORT filings yet. We sweep new filings monthly.